ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.779,54
-0,58%
S&P 500
5.306,04
0,02%
US Dollar vs BRL
5,1616
-0,02%
Bitcoin
67.831,72
-0,67%
Brent Oil
84,57
0,29%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ImmuCell Corporation (ICCC)

  7. ImmuCell Corporation (ICCC) Notícias

ICCC

ImmuCell (ICCC)

ImmuCell Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ICCC
DataHoraFonteTítuloCódigoCompanhia
22/05/202417:50Edgar (US Regulatory)Form SCHEDULE 13D - General statement of acquisition of beneficial ownershipNASDAQ:ICCCImmuCell Corporation
14/05/202417:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
14/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
14/05/202417:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
08/05/202414:00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
09/04/202417:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024NASDAQ:ICCCImmuCell Corporation
27/02/202418:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
16/02/202411:30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
08/01/202418:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023NASDAQ:ICCCImmuCell Corporation
13/11/202318:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
07/11/202314:15GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
05/10/202317:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023NASDAQ:ICCCImmuCell Corporation
06/09/202313:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
29/08/202309:00GlobeNewswire Inc.ImmuCell Announces Submission of CMC Technical Section to the FDANASDAQ:ICCCImmuCell Corporation
10/08/202317:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
07/08/202313:00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
13/07/202315:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ICCCImmuCell Corporation
11/07/202317:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023NASDAQ:ICCCImmuCell Corporation
29/06/202314:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ICCCImmuCell Corporation
28/06/202317:05GlobeNewswire Inc.ImmuCell Announces Change in Timing of Anticipated FDA SubmissionNASDAQ:ICCCImmuCell Corporation
21/06/202317:05GlobeNewswire Inc.ImmuCell Appoints Bryan K. Gathagan to Board of DirectorsNASDAQ:ICCCImmuCell Corporation
15/06/202317:05GlobeNewswire Inc.ImmuCell Announces Approval of Principal Terms of a $3 Million Debt FacilityNASDAQ:ICCCImmuCell Corporation
16/05/202310:00GlobeNewswire Inc.ImmuCell to Hold Virtual-Only Annual Meeting of StockholdersNASDAQ:ICCCImmuCell Corporation
11/05/202317:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ICCCImmuCell Corporation
11/05/202317:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
04/05/202307:30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
28/04/202311:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ICCCImmuCell Corporation
28/04/202311:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ICCCImmuCell Corporation
18/04/202318:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ICCCImmuCell Corporation
05/04/202317:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023NASDAQ:ICCCImmuCell Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:ICCC

Seu Histórico Recente

BIT
WICC24
International Care
EU
IDVA
BlackRock Asset Manageme...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados